Apixaban 5 mg in Egypt

Dear Doctors

#Cardiologist

#Vascular_surgeon

#Zeta_pharma has the honor to introduce for your #patients

#Apixaban_5_mg

#Elimbosis_5_mg

10 tab

#Price 89.75

Breakthrough in PCI

Protected PCI with Impella 2.5 reduces adverse events, with a 29% reduction in MACCE at 90 days

A Protected PCI is an Impella-supported procedure that maintains a patient’s hemodynamic stability, allowing you to do a more complete revascularization in a single session.

The Impella 2.5 is a temporary (≤ 6 hours) ventricular support device indicated for use during:

1-High risk PCI performed in urgent or

 2-Elective hemodynamically stable patients with severe coronary artery disease and 3-Depressed left ventricular ejection fraction, when a heart team, including a cardiac surgeon, has determined high risk PCI is the appropriate therapeutic option. Use of the Impella 2.5 in these patients may prevent hemodynamic instability that may occur during planned temporary coronary occlusions and may reduce peri- and post-procedural adverse events.

Impella is the only hemodynamic support device proven safe and effective at reducing adverse events in elective and urgent high risk PCI patients

The FDA indication for high risk PCI is defined as the combination of complex coronary artery disease (3VD or ULM), hemodynamic compromise (LVEF <=35%) and patient comorbidities.